Mometasone Rowex (Mometasone Furoate)

Mometasone furoate acts as an agonist at glucocorticoid receptors within nasal mucosal cells. Activation of these receptors alters gene transcription, suppressing inflammatory cytokine production and limiting immune cell infiltration, which together decrease swelling and nasal symptoms.

The specific dosing regimen for Mometasone Rowex is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data for mometasone furoate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometasone Rowex contains mometasone furoate, a high‑potency corticosteroid with minimal systemic absorption when used as directed. Compared with older agents such as beclomethasone, it often provides effective symptom control at lower daily doses, but the choice of therapy should be individualized by the prescriber.

Store the nasal spray at room temperature, away from direct sunlight and moisture. Keep the product in its original packaging until use, and ensure the cap is tightly closed to maintain spray integrity.

Mometasone Rowex is administered as a nasal spray. The patient should gently blow the nose, insert the nozzle into one nostril, close the opposite nostril, and spray the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed.

Serious risks, though rare, include nasal septal perforation, severe allergic reactions such as anaphylaxis, adrenal suppression with prolonged use, and opportunistic fungal infections of the nasal cavity. Patients should report any unusual bleeding, persistent pain, or signs of infection promptly.

Mometasone Rowex should be avoided in individuals with known hypersensitivity to mometasone furoate or any component of the formulation, and in patients with active untreated nasal infections or recent nasal surgery unless cleared by a physician.